应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01302 先健科技
未开盘 08-21 16:08:08
1.370
+0.005
+0.37%
最高
1.375
最低
1.335
成交量
1,078万
今开
1.365
昨收
1.365
日振幅
2.93%
总市值
63.46亿
流通市值
63.46亿
总股本
46.32亿
成交额
1,462万
换手率
0.23%
流通股本
46.32亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股异动 | 先健科技(01302.HK)跌超3% 中期纯利预降约50%至54% 收入下降及汇兑收益减少拖累
智通财经 · 08-13
港股异动 | 先健科技(01302.HK)跌超3% 中期纯利预降约50%至54% 收入下降及汇兑收益减少拖累
先健科技(01302)发盈警 预计上半年股东应占亏损3000万元至4000万元
智通财经 · 08-12
先健科技(01302)发盈警 预计上半年股东应占亏损3000万元至4000万元
先健科技:预计2026年上半年归母净利润达1.1亿至1.2亿元人民币
美股速递 · 08-12
先健科技:预计2026年上半年归母净利润达1.1亿至1.2亿元人民币
先健科技(01302)发盈利预警:2026年上半年扣除非经常性项目后预盈1.1亿至1.2亿元
公告速递 · 08-12
先健科技(01302)发盈利预警:2026年上半年扣除非经常性项目后预盈1.1亿至1.2亿元
先健科技(01302):方宇获委任为授权代表
智通财经 · 08-12
先健科技(01302):方宇获委任为授权代表
先健科技(01302)委任方宇为上市规则3.05条下公司授权代表
公告速递 · 08-12
先健科技(01302)委任方宇为上市规则3.05条下公司授权代表
先健科技(01302)拟于8月28日召开董事会 审议2026年中期业绩及派息事宜
公告速递 · 08-12
先健科技(01302)拟于8月28日召开董事会 审议2026年中期业绩及派息事宜
先健科技2026年7月股份变动月报表:股本维持不变
公告速递 · 08-04
先健科技2026年7月股份变动月报表:股本维持不变
先健科技(01302)宣布终止收购华医股权及发行可换股债券计划
公告速递 · 07-20
先健科技(01302)宣布终止收购华医股权及发行可换股债券计划
先健科技公告重大交易:拟收购星途股权并发行可转换债券
美股速递 · 07-20
先健科技公告重大交易:拟收购星途股权并发行可转换债券
【券商聚焦】中信建投:建议关注Q2医疗设备高增长公司配置机会
金吾财讯 · 07-17
【券商聚焦】中信建投:建议关注Q2医疗设备高增长公司配置机会
先健科技6月股份变动月报表披露,股本维持稳定
公告速递 · 07-03
先健科技6月股份变动月报表披露,股本维持稳定
先健科技(01302):姜峰调任为独立非执行董事
智通财经 · 06-18
先健科技(01302):姜峰调任为独立非执行董事
【券商聚焦】中信建投:建议2026年加配医疗器械板块
金吾财讯 · 06-18
【券商聚焦】中信建投:建议2026年加配医疗器械板块
先健科技2026年5月股份变动月报表:股本维持稳定
公告速递 · 06-02
先健科技2026年5月股份变动月报表:股本维持稳定
新华健康 | 高瓴资本意欲何为? 三度交易华医圣杰股权引追问
经济参考网 · 05-28
新华健康 | 高瓴资本意欲何为? 三度交易华医圣杰股权引追问
港股异动 | 先健科技(01302)跌超15% 拟18.7亿元收购华医圣杰96.46%股权 以可换股债券支付代价
智通财经 · 05-26
港股异动 | 先健科技(01302)跌超15% 拟18.7亿元收购华医圣杰96.46%股权 以可换股债券支付代价
先健科技拟18.733亿元收购北京华医圣杰科技约96.46%股权
新浪港股 · 05-26
先健科技拟18.733亿元收购北京华医圣杰科技约96.46%股权
先健科技拟18.733亿元收购北京华医圣杰科技约96.46%股权
新浪港股 · 05-24
先健科技拟18.733亿元收购北京华医圣杰科技约96.46%股权
先健科技拟通过可转债收购思达医疗科技96.46%股权
投资观察 · 05-22
先健科技拟通过可转债收购思达医疗科技96.46%股权
加载更多
公司概况
公司名称:
先健科技
所属市场:
SEHK
上市日期:
--
主营业务:
先健科技公司是一家主要从事开发、制造及买卖心血管及外周血管疾病及紊乱所用微创介入医疗器械的投资控股公司。该公司主要通过三个分部运营其业务。结构性心脏病业务分部从事买卖、制造及研发与结构性心脏病有关的器械。外周血管病业务分部从事买卖、制造及研发与外周血管病有关的器械。起搏电生理业务分部从事买卖、制造及研发与起搏电生理有关的器械。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01302","market":"HK","secType":"STK","nameCN":"先健科技","latestPrice":1.37,"timestamp":1787299688005,"preClose":1.365,"halted":0,"volume":10776000,"delay":0,"changeRate":0.0036630036630037476,"floatShares":4632000000,"shares":4632000000,"eps":0.03849862008404943,"marketStatus":"未开盘","change":0.005,"latestTime":"08-21 16:08:08","open":1.365,"high":1.375,"low":1.335,"amount":14616360,"amplitude":0.029304,"askPrice":1.37,"askSize":220000,"bidPrice":1.365,"bidSize":54000,"shortable":3,"etf":0,"ttmEps":0.03849862008404943,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"listingDate":1320854400000,"exchange":"SEHK","adjPreClose":1.365,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.9539660056741676,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01302","defaultTab":"news","newsList":[{"id":"2659218779","title":"港股异动 | 先健科技(01302.HK)跌超3% 中期纯利预降约50%至54% 收入下降及汇兑收益减少拖累","url":"https://stock-news.laohu8.com/highlight/detail?id=2659218779","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659218779?lang=zh_cn&edition=full","pubTime":"2026-08-13 11:21","pubTimestamp":1786591285,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","BK1600","01302","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658970046","title":"先健科技(01302)发盈警 预计上半年股东应占亏损3000万元至4000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658970046","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658970046?lang=zh_cn&edition=full","pubTime":"2026-08-12 21:19","pubTimestamp":1786540753,"startTime":"0","endTime":"0","summary":"该等非经常性项目包括以股份为基础的付款开支、按公平值计入损益的金融资产的其他损益及与涉及董事会已决议不予推进的北京华医圣杰科技有限公司股权收购及发行可换股债券的主要交易有关的预期交易费用。考虑该等非经常性项目的影响,集团预期截至2026年6月30日止六个月将取得公司拥有人应占亏损介于人民币3000万元至4000万元之间,而2025年同期取得公司拥有人应占纯利约人民币5510万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"先健科技(01302)发盈警 预计上半年股东应占亏损3000万元至4000万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1600","01302","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165318899","title":"先健科技:预计2026年上半年归母净利润达1.1亿至1.2亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1165318899","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165318899?lang=zh_cn&edition=full","pubTime":"2026-08-12 21:12","pubTimestamp":1786540369,"startTime":"0","endTime":"0","summary":"先健科技(LIFETECH SCI)发布业绩预告,预期截至2026年6月30日止六个月的归属于公司所有者的净利润将落在人民币1.1亿元至1.2亿元区间内。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1100","BK1583","01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166287078","title":"先健科技(01302)发盈利预警:2026年上半年扣除非经常性项目后预盈1.1亿至1.2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166287078","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166287078?lang=zh_cn&edition=full","pubTime":"2026-08-12 21:11","pubTimestamp":1786540281,"startTime":"0","endTime":"0","summary":"2026年8月12日,先健科技发布盈利预警称,依据截至2026年6月30日止六个月的未经审计综合管理账目及董事会初步评估,若剔除若干非经常性项目影响,预计期内录得本公司拥有人应占纯利约人民币1.1亿元至1.2亿元;而2025年同期录得纯利约人民币2.385亿元。公司计划于2026年8月底前公布截至2026年6月30日止六个月的中期业绩。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658097058","title":"先健科技(01302):方宇获委任为授权代表","url":"https://stock-news.laohu8.com/highlight/detail?id=2658097058","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658097058?lang=zh_cn&edition=full","pubTime":"2026-08-12 20:56","pubTimestamp":1786539413,"startTime":"0","endTime":"0","summary":"智通财经APP讯,先健科技(01302)发布公告,执行董事方宇先生已获委任为香港联合交易所有限公司证券上市规则第3.05条项下的公司授权代表,自2026年8月12日起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479148.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1600","BK1583","01302","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146608101","title":"先健科技(01302)委任方宇为上市规则3.05条下公司授权代表","url":"https://stock-news.laohu8.com/highlight/detail?id=1146608101","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146608101?lang=zh_cn&edition=full","pubTime":"2026-08-12 20:55","pubTimestamp":1786539333,"startTime":"0","endTime":"0","summary":"2026年8月12日,先健科技(01302)公告称,公司执行董事方宇已获董事会委任为香港联合交易所有限公司证券上市规则3.05条项下的公司授权代表,任命自2026年8月12日起生效。\n公告显示,方宇的加入后,公司在上市规则3.05条项下的授权代表将由谢粤辉与方宇共同担任。该任命与2026年5月22日公布的刘剑雄先生辞任执行董事及授权代表的事项衔接。\n截至本公告日期,先健科技董事会成员包括:执行董事谢粤辉,独立非执行董事吴丽萍、方宇、陈东霞、姜峰及周路明。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199226420","title":"先健科技(01302)拟于8月28日召开董事会 审议2026年中期业绩及派息事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1199226420","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199226420?lang=zh_cn&edition=full","pubTime":"2026-08-12 19:31","pubTimestamp":1786534286,"startTime":"0","endTime":"0","summary":"本报讯 先健科技(01302)8月12日公告称,公司董事会已定于2026年8月28日(星期五)召开会议,主要议程包括:\n1. 审议并批准先健科技及其附属公司截至2026年6月30日止六个月的未经审核中期业绩,并通过在香港交易及结算所有限公司及公司官网刊登相关业绩公告;\n2. 研究及决定是否派发中期股息;\n3. (如有需要)审议暂时停止办理公司股份过户登记手续;\n4. 处理其他相关事项。\n本次董事会由执行董事、董事会主席兼首席执行官谢粤辉先生召集。董事会现任成员包括执行董事谢粤辉先生、吴丽萍女士及方宇先生;以及独立非执行董事周路明先生、陈东霞女士及姜峰先生。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107144595","title":"先健科技2026年7月股份变动月报表:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1107144595","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107144595?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:41","pubTimestamp":1785832889,"startTime":"0","endTime":"0","summary":"先健科技公司于2026年8月4日发布2026年7月股份变动月报表。公告显示,公司在2026年7月并未进行任何新股发行、股份购回或股票注销,整个报告期内股本总数保持稳定。报告期末,已发行股份总数为4,631,712,400股,库藏股为0股,分别与上月末持平。股权激励方面,公司于报告期内并无因行使股票期权而新增发行股份,月内行权产生资金金额为0港元。公司在公告中确认其已符合适用的公众持股量要求,并承诺遵守香港联交所《上市规则》及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176798974","title":"先健科技(01302)宣布终止收购华医股权及发行可换股债券计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1176798974","media":"公告速递","labels":["executive","merge","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176798974?lang=zh_cn&edition=full","pubTime":"2026-07-20 19:13","pubTimestamp":1784545981,"startTime":"0","endTime":"0","summary":"香港,2026年7月20日,先健科技有限公司发布公告称,公司董事会已决定不再推进此前拟议的收购华医股权及根据特别授权发行可换股债券的主要交易。公告显示,先健科技与卖方就股权购买协议及可换股债券票据等最终交易文件已进行谈判,但双方迄今未能达成一致。基于审慎考虑并为消除潜在不确定因素,董事会决定终止交易;相关的可换股债券发行及特别授权事项亦将不再进行,公司亦不会就此向股东寄发通函或召开股东特别大会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,merge,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100235998","title":"先健科技公告重大交易:拟收购星途股权并发行可转换债券","url":"https://stock-news.laohu8.com/highlight/detail?id=1100235998","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100235998?lang=zh_cn&edition=full","pubTime":"2026-07-20 18:52","pubTimestamp":1784544763,"startTime":"0","endTime":"0","summary":"先健科技宣布一项重大交易,涉及拟收购星途股权以及计划发行可转换债券。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302","BK1600","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652785473","title":"【券商聚焦】中信建投:建议关注Q2医疗设备高增长公司配置机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2652785473","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652785473?lang=zh_cn&edition=full","pubTime":"2026-07-17 08:56","pubTimestamp":1784249774,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指,板块26Q1业绩整体承压。医疗设备预计Q2招标偏弱,部分企业新品及海外驱动增长;医疗器械上游部分公司收入有望高增长;高值耗材受医疗合规要求提升影响,部分企业预计增长良好;IVD低基数下增速有望改善;家用器械部分企业有望延续高增长;医疗服务边际有所回暖。建议关注Q2高增长公司的配置机会,建议关注国产替代向中高端延伸,看好出海、新科技(AI、脑机接口)及并购整合等新技术落地。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986094","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1502","LU0287142896.SGD","BK1615","02190","BK1587","BK1501","02252","BK1222","HK0000165453.HKD","BK1142","BK1591","01066","00853","BK1589","BK1571","LU0173614495.USD","BK1161","159873","BK1593","601066","06826","BK1617","BK1583","BK1610","BK1515","09996","BK1574","BK1600","BK1247","02235","BK1584","BK1189","KCE","BK0276","00241","BK1585","01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103534765","title":"先健科技6月股份变动月报表披露,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1103534765","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103534765?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:56","pubTimestamp":1783068990,"startTime":"0","endTime":"0","summary":"2026年7月3日,先健科技披露了公司截至2026年6月30日的股份变动月报表。公告显示,公司本月底法定/注册股本总额为USD 50,000,与上月保持一致。法定/注册股份数目仍为40,000,000,000股,面值USD 0.00000125。截至报告期末,已发行股份总数为4,631,712,400股,与上月底相比无增减变动。公告指出,当月无新增发行股份或回购、注销及库藏股变动,整体股本保持稳定。本月内未通过期权行使产生新增发行股份或库藏股转让。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644401085","title":"先健科技(01302):姜峰调任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2644401085","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644401085?lang=zh_cn&edition=full","pubTime":"2026-06-18 20:48","pubTimestamp":1781786933,"startTime":"0","endTime":"0","summary":"智通财经APP讯,先健科技(01302)发布公告,姜峰先生已由非执行董事调任为独立非执行董事,并已获委任为审核委员会及薪酬委员会各自的成员,自2026年6月18日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1600","BK1583","01302","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644732297","title":"【券商聚焦】中信建投:建议2026年加配医疗器械板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2644732297","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644732297?lang=zh_cn&edition=full","pubTime":"2026-06-18 09:24","pubTimestamp":1781745845,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券建议,2026年加配医疗器械板块,短期来看,建议把握2026年业绩改善个股的业绩和估值修复机会,多家医疗器械行业细分赛道龙头公司将于2026年迎来加速增长,同时建议关注手术机器人、脑机接口等新科技方向,相关技术突破和商业化落地有望持续催化板块热度。长期来看,医疗器械板块投资机会来自创新、出海和并购整合,板块的创新和国际化能力得到认可,估值正在重构。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984058","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826","BK1502","HK0000165453.HKD","BK1571","BK0276","BK1587","BK1589","BK1142","01066","02190","BK1161","BK1515","BK1189","BK1247","BK1574","BK1600","LU0287142896.SGD","00853","BK1100","01302","BK1501","00241","BK1615","02252","09996","BK1617","BK1222","BK1583","BK1584","BK1610","BK1591","BK1593","LU0173614495.USD","159883","02235","BK1585","601066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106837755","title":"先健科技2026年5月股份变动月报表:股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1106837755","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106837755?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:16","pubTimestamp":1780391797,"startTime":"0","endTime":"0","summary":"先健科技公司于2026年6月2日发布2026年5月的证券变动月报表。报告显示,公司本月股本结构维持稳定,已发行股份数量及注册股本未发生变化。根据公告,截至2026年5月31日,先健科技的法定/注册股本仍为40,000,000,000股,每股面值为0.00000125美元,总计50,000美元,与上月保持一致。截至2026年5月末,先健科技股本总数依然维持在4,631,712,400股,同时符合香港联合交易所有限公司规定的最低公众持股量要求。本次公告由公司秘书刘剑雄签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638365694","title":"新华健康 | 高瓴资本意欲何为? 三度交易华医圣杰股权引追问","url":"https://stock-news.laohu8.com/highlight/detail?id=2638365694","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638365694?lang=zh_cn&edition=full","pubTime":"2026-05-28 22:30","pubTimestamp":1779978629,"startTime":"0","endTime":"0","summary":"同一公司,高瓴资本先将其卖给健世科技(09877.HK),两年后又从健世科技手中买回来。如今,高瓴资本又将其卖给先健科技(01302.HK)。这笔交易一经披露,随即引起业界关注:高瓴资本如此腾挪意欲何为?先健科技近日披露了最新的交易方案。按照协议,公司拟作价18.73亿元收购北京华医圣杰科技有限公司(简称“华医圣杰”)96.46%股权,交易对手穿透后由高瓴资本控制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605283753111580.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605283753111580.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1100","BK1600","BK1583","09877","01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638562912","title":"港股异动 | 先健科技(01302)跌超15% 拟18.7亿元收购华医圣杰96.46%股权 以可换股债券支付代价","url":"https://stock-news.laohu8.com/highlight/detail?id=2638562912","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638562912?lang=zh_cn&edition=full","pubTime":"2026-05-26 11:00","pubTimestamp":1779764421,"startTime":"0","endTime":"0","summary":"消息面上,5月22日晚,先健科技发布公告称,拟以代价约18.733亿元向高瓴资本全资持有之AUT-VII收购国内先心封堵器厂商华医圣杰约96.46%股权,代价全部以发行可换股债券支付,双方并订立具法律约束力的框架协议。公告指出,可换股债券按年利率3.5%计息,每季以现金支付,为期3年,初始转换价为每股2.5港元,比5月22日收报2.31港元溢价约8.2%,悉数行使涉发行约8.6亿股新股,占扩大后股本约15.66%,将令高瓴成为先健科技的单一最大股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1600","BNDW","BK1583","BK1100","01302","BK4585","VXUS","BK4588"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2638660845","title":"先健科技拟18.733亿元收购北京华医圣杰科技约96.46%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2638660845","media":"新浪港股","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638660845?lang=zh_cn&edition=full","pubTime":"2026-05-26 08:52","pubTimestamp":1779756720,"startTime":"0","endTime":"0","summary":" 先健科技发布公告,于2026年5月22日,公司拟向卖方AUT-VII HK Holdings Limited收购北京华医圣杰科技有限公司(华医)约96.46%股权。交易代价约为人民币18.733亿元。代价将由公司向卖方发行可换股债券予以支付。交割后,华医将成为公司的非全资附属公司,其财务业绩将并入集团的综合财务报表。华医的产品主要用于治疗先天性心脏缺损及预防心因性栓塞性中风。董事认为,收购华医符合集团的整体发展策略,并将为公司带来长远的裨益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-05-26/doc-inhzequs2977158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","01302","BK1583","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637308535","title":"先健科技拟18.733亿元收购北京华医圣杰科技约96.46%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2637308535","media":"新浪港股","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637308535?lang=zh_cn&edition=full","pubTime":"2026-05-24 16:27","pubTimestamp":1779611220,"startTime":"0","endTime":"0","summary":" 先健科技发布公告,于2026年5月22日,公司拟向卖方AUT-VII HK Holdings Limited收购北京华医圣杰科技有限公司(华医)约96.46%股权。交易代价约为人民币18.733亿元。代价将由公司向卖方发行可换股债券予以支付。交割后,华医将成为公司的非全资附属公司,其财务业绩将并入集团的综合财务报表。华医的产品主要用于治疗先天性心脏缺损及预防心因性栓塞性中风。董事认为,收购华医符合集团的整体发展策略,并将为公司带来长远的裨益。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-05-24/doc-inhyytnk3397355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1600","01302","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193455178","title":"先健科技拟通过可转债收购思达医疗科技96.46%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1193455178","media":"投资观察","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193455178?lang=zh_cn&edition=full","pubTime":"2026-05-22 23:27","pubTimestamp":1779463664,"startTime":"0","endTime":"0","summary":"先健科技公司(股票代码:1302.HK)宣布,计划通过发行可转换债券的方式,收购思达医疗科技公司96.46%的股权。此项交易旨在进一步整合医疗技术资源,拓展公司在相关领域的业务布局。市场分析人士指出,此次收购若顺利完成,或将增强先健科技在医疗器械细分市场的竞争力,并为其带来新的增长动力。具体交易条款及后续进展有待公司进一步披露。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","01302","BK1600","BK1583"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lifetechmed.com","stockEarnings":[{"period":"1week","weight":-0.0214},{"period":"1month","weight":-0.0352},{"period":"3month","weight":-0.4069},{"period":"6month","weight":-0.1941},{"period":"1year","weight":-0.3657},{"period":"ytd","weight":-0.1218}],"compareEarnings":[{"period":"1week","weight":0.0355},{"period":"1month","weight":0.0449},{"period":"3month","weight":0.0158},{"period":"6month","weight":-0.0153},{"period":"1year","weight":0.036},{"period":"ytd","weight":0.0148}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"先健科技公司是一家主要从事开发、制造及买卖心血管及外周血管疾病及紊乱所用微创介入医疗器械的投资控股公司。该公司主要通过三个分部运营其业务。结构性心脏病业务分部从事买卖、制造及研发与结构性心脏病有关的器械。外周血管病业务分部从事买卖、制造及研发与外周血管病有关的器械。起搏电生理业务分部从事买卖、制造及研发与起搏电生理有关的器械。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.025079},{"month":2,"riseRate":0.384615,"avgChangeRate":0.028221},{"month":3,"riseRate":0.615385,"avgChangeRate":0.017514},{"month":4,"riseRate":0.538462,"avgChangeRate":0.025302},{"month":5,"riseRate":0.538462,"avgChangeRate":0.072446},{"month":6,"riseRate":0.538462,"avgChangeRate":0.041537},{"month":7,"riseRate":0.461538,"avgChangeRate":-0.056658},{"month":8,"riseRate":0.230769,"avgChangeRate":-0.050933},{"month":9,"riseRate":0.583333,"avgChangeRate":0.031147},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.004062},{"month":11,"riseRate":0.416667,"avgChangeRate":0.043537},{"month":12,"riseRate":0.384615,"avgChangeRate":0.000564}],"exchange":"SEHK","name":"先健科技","nameEN":"LIFETECH SCI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"先健科技(01302)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供先健科技(01302)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"先健科技,01302,先健科技股票,先健科技股票老虎,先健科技股票老虎国际,先健科技行情,先健科技股票行情,先健科技股价,先健科技股市,先健科技股票价格,先健科技股票交易,先健科技股票购买,先健科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"先健科技(01302)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供先健科技(01302)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}